title: X-linked severe combined immunodeficiency.
abstract: Severe combined immunodeficiency is one of the most common causes of primary immunodeficiencies in humans. Molecular biological techniques have allowed new, therapeutically useful treatments for these diseases to be introduced into clinical practice. This review will focus on the molecular basis and new treatments for X-linked severe combined immunodeficiency.
authors.affiliation: Glasgow Royal Infirmary, Glasgow G4 0SF.
authors.forename: A C
authors.initials: AC
authors.lastname: Church
mesh_terms: D016026:Bone Marrow Transplantation / Q000379:methods; D002450:Cell Communication; D016207:Cytokines / Q000627:therapeutic use; D040181:Genetic Diseases, X-Linked / Q000188:drug therapy* / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D016511:Severe Combined Immunodeficiency / Q000188:drug therapy* / Q000235:genetics
chemical_list: D016207:Cytokines